| Package | hl7.fhir.uv.pddi |
| Resource Type | ValueSet |
| Id | valueset-cyclosporine-exclude |
| FHIR Version | R4 |
| Source | http://hl7.org/fhir/uv/pddi/https://build.fhir.org/ig/HL7/PDDI-CDS/ValueSet-valueset-cyclosporine-exclude.html |
| URL | http://hl7.org/fhir/uv/pddi/ValueSet/valueset-cyclosporine-exclude |
| Version | 1.0.0-ballot |
| Status | draft |
| Date | 2018-07-02 |
| Name | Valueset_cyclosporine_exclude |
| Title | Exclude cyclosporine Medications Value Set |
| Realm | uv |
| Authority | hl7 |
| Description | ValueSet containing drug identifiers to exclude. Criteria is explicitly stating ophthalmic formulations. |
| Purpose | To refine valueset for Digoxin + Cyclosporine PDDI-CDS |
| Copyright | (copyright expectations unknown) |
No resources found
| CodeSystem | |
| rxnorm | RxNorm |
Note: links and images are rebased to the (stated) source
Generated Narrative: ValueSet valueset-cyclosporine-exclude
http://www.nlm.nih.gov/research/umls/rxnorm| Code | Display |
| 1093178 | Cyclosporine 0.002 MG/MG Ophthalmic Ointment [Optimmune] |
| 402092 | Cyclosporine 0.5 MG/ML Ophthalmic Suspension [Restasis] |
| 1093177 | Cyclosporine Ophthalmic Ointment [Optimmune] |
| 402330 | Cyclosporine Ophthalmic Suspension [Restasis] |
| 1093174 | Cyclosporine 0.002 MG/MG Ophthalmic Ointment |
| 351291 | Cyclosporine 0.5 MG/ML Ophthalmic Suspension |
| 1093173 | Cyclosporine Ophthalmic Ointment |
| 378766 | Cyclosporine Ophthalmic Suspension |
| 1156187 | Cyclosporine Ophthalmic Product |
| 1182342 | Optimmune Ophthalmic Product |
| 1182527 | Restasis Ophthalmic Product |
{
"resourceType": "ValueSet",
"id": "valueset-cyclosporine-exclude",
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
"valueCode": "cds"
}
],
"url": "http://hl7.org/fhir/uv/pddi/ValueSet/valueset-cyclosporine-exclude",
"version": "1.0.0-ballot",
"name": "Valueset_cyclosporine_exclude",
"title": "Exclude cyclosporine Medications Value Set",
"status": "draft",
"experimental": true,
"date": "2018-07-02",
"publisher": "HL7 Clinical Decision Support Workgroup",
"contact": [
{
"telecom": [
{
"system": "url",
"value": "http://hl7.org/Special/committees/dss"
}
]
}
],
"description": "ValueSet containing drug identifiers to exclude. Criteria is explicitly stating ophthalmic formulations.",
"jurisdiction": [
{
"coding": [
{
"system": "http://unstats.un.org/unsd/methods/m49/m49.htm",
"code": "001"
}
]
}
],
"purpose": "To refine valueset for Digoxin + Cyclosporine PDDI-CDS",
"copyright": "(copyright expectations unknown)",
"compose": {
"include": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept": [
{
"code": "1093178",
"display": "Cyclosporine 0.002 MG/MG Ophthalmic Ointment [Optimmune]"
},
{
"code": "402092",
"display": "Cyclosporine 0.5 MG/ML Ophthalmic Suspension [Restasis]"
},
{
"code": "1093177",
"display": "Cyclosporine Ophthalmic Ointment [Optimmune]"
},
{
"code": "402330",
"display": "Cyclosporine Ophthalmic Suspension [Restasis]"
},
{
"code": "1093174",
"display": "Cyclosporine 0.002 MG/MG Ophthalmic Ointment"
},
{
"code": "351291",
"display": "Cyclosporine 0.5 MG/ML Ophthalmic Suspension"
},
{
"code": "1093173",
"display": "Cyclosporine Ophthalmic Ointment"
},
{
"code": "378766",
"display": "Cyclosporine Ophthalmic Suspension"
},
{
"code": "1156187",
"display": "Cyclosporine Ophthalmic Product"
},
{
"code": "1182342",
"display": "Optimmune Ophthalmic Product"
},
{
"code": "1182527",
"display": "Restasis Ophthalmic Product"
}
]
}
]
}
}